All Stories

  1. Vitamin C and cardiovascular disease
  2. The UK’s vitamin C recommendations are not evidence-based
  3. Common cold treatments: a new method for analyzing their effects
  4. Vitamin C in infectious diseases: Misrepresentation of the evidence
  5. Cochrane review on zinc for the common cold (2024) misleads readers
  6. Errors in a Meta-analysis on Vitamin C and COVID-19
  7. Vitamin C for the common cold and pneumonia
  8. Cochrane review on zinc for the common cold (2024) misled readers
  9. Vitamin C for patients with sepsis?
  10. Evidence-based treatment of the common cold with zinc lozenges
  11. Rebound effect explains the divergence in survival after 5 days in a controlled trial on vitamin C for COVID-19 patients
  12. Response: Commentary: Quantile treatment effect of zinc lozenges on common cold duration: a novel approach to analyze the effect of treatment on illness duration
  13. Scurvy can cause pulmonary hypertension
  14. Vitamin C reduces the severity of colds
  15. Concerns with the revised Japanese recommendation for administering vitamin C to septic patients
  16. Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis
  17. Zinc and Coronavirus Disease 2019
  18. Vitamin C: abrupt termination may increase mortality of sepsis patients
  19. Pitfalls in choosing data examples for methodological work: Bayesian approaches to a fixed effects meta‐analysis of zinc lozenges for the common cold
  20. Vitamin C and the risk of atrial fibrillation: Mendelian randomization study may be misleading
  21. Vitamin C and the risk of cardiovascular diseases: Mendelian randomization study may be misleading
  22. Vitamin C may improve the mechanical efficiency of the heart
  23. Mendelian randomization can lead to flawed conclusions about the effects of vitamin C
  24. Quantile treatment effect of zinc lozenges on common cold duration: a novel approach
  25. Bias against vitamin C has hampered the recognition of positive findings from randomized trials
  26. Vitamin C and zinc lozenges for COVID-19?
  27. Carrageenan nasal spray can shorten the common cold and the effect is greater on longer colds
  28. Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial
  29. Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19
  30. Vitamin C may increase the recovery rate of outpatient cases of SARS-CoV-2 infection by 70%: reanalysis of the COVID A to Z Randomized Clinical Trial
  31. Commentary: Vitamin C supplementation for prevention and treatment of pneumonia
  32. Vitamin C and COVID-19
  33. Benefit of OTC Formula Against COVID-19 Is Explained by Selection Bias
  34. Comment on “Therapeutic target and molecular mechanism of vitamin C-treated pneumonia: a systematic study of network pharmacology” by R. Li, C. Guo, Y. Li, X. Liang, L. Yang and W. Huang, Food Funct., 2020, 11, 4765
  35. Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: re-analysis of randomized trial data
  36. Reanalysis of the Effect of Vitamin C on Mortality in the CITRIS-ALI Trial: Important Findings Dismissed in the Trial Report
  37. Cochrane has not consistently followed the COPE guidelines
  38. The current vitamin E recommendation in the USA is not supported by new empirical evidence
  39. Vitamin C for Cardiac Surgery Patients: Several Errors in a Published Meta-Analysis. Comment on “Effects of Vitamin C on Organ Function in Cardiac Surgery Patients: A Systematic Review and Meta-Analysis. Nutrients 2019, 11, 2103”
  40. Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis
  41. Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial
  42. The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
  43. Vitamin C as a Possible Therapy for COVID-19
  44. Many continuous variables should be analyzed using the relative scale: a case study of β2-agonists for preventing exercise-induced bronchoconstriction
  45. Zinc for preventing and treating the common cold
  46. Meta-analysis on vitamin C and the common cold in children may be misleading
  47. Random-Effects Assumption in Meta-analyses
  48. Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis
  49. Errors in a meta-analysis on vitamin C and post-operative atrial fibrillation
  50. Effect of β-Carotene Supplementation on the Risk of Pneumonia Is Heterogeneous in Males: Effect Modification by Cigarette Smoking
  51. Letter: Comparison of different vitamin E forms is confounded by heterogeneity in vitamin E effects
  52. Vitamin C in Clinical Therapeutics
  53. Zinc for preventing and treating the common cold
  54. Erroneus calculation of sample size in a vitamin C and atrial fibrillation trial
  55. Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale: a case study of two zinc lozenge trials
  56. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage
  57. Vitamins E and C May Differ in Their Effect on Contrast-Induced Acute Kidney Injury
  58. Vitamin E May Protect Against Contrast-Induced Acute Kidney Injury
  59. Vitamin C and Infections
  60. Publication bias in meta-analysis of ascorbic acid for postoperative atrial fibrillation
  61. Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis
  62. Zinc lozenges may triple the recovery rate of common cold patients
  63. Vitamin E and the risk of pneumonia: using the I 2 statistic to quantify heterogeneity within a controlled trial
  64. Many continuous variables such as the duration of the common cold should be analyzed using the relative scale
  65. Vitamin E administration may decrease the incidence of pneumonia in elderly males
  66. Zinc acetate lozenges may shorten common cold duration by 3 days
  67. Vitamin C for treating atrial fibrillation
  68. Thomas Chalmers, vitamin C and the common cold
  69. Zinc lozenges and vitamin C for the common cold are not examples of placebo effect in action
  70. Common Cold Treatment Using Zinc
  71. Impure placebo is a useless concept
  72. Exercise, Antioxidants, and the Risk for Pneumonia
  73. Zinc acetate lozenges may shorten common cold-associated nasal discharge by 34% and cough by 46%
  74. Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent Swimmers: A Randomized Controlled Trial
  75. Vitamin C for treating atrial fibrillation
  76. The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis
  77. Vitamin C and asthma
  78. Clinical use of placebo treatments may undermine the trust of patients: a response to Gold and Lichtenberg
  79. Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer
  80. Can CAM treatments be evidence‐based?
  81. Does Exercise Prevent the Common Cold?
  82. The Effect of Vitamin E on Mortality Is Not Uniform across the Population
  83. Vitamin C Should Be Tested against Exercise-induced Bronchoconstriction
  84. Vitamin C and common cold-induced asthma: a systematic review and statistical analysis
  85. Vitamin C for preventing and treating tetanus
  86. Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm?
  87. Vitamin C for preventing and treating pneumonia
  88. Vitamin supplements and mortality in older people
  89. Vitamin C may alleviate exercise-induced bronchoconstriction: a meta-analysis
  90. Placebo Use in the United Kingdom: Results from a National Survey of Primary Care Practitioners
  91. Vitamin C for preventing and treating the common cold
  92. Zinc lozenges may shorten common cold duration
  93. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials
  94. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
  95. Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density
  96. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
  97. Erratum to: Vitamin C and asthma in children: modification of the effect by age, exposure to dampness and the severity of asthma
  98. Vitamin C and Community-acquired Pneumonia
  99. Zinc Lozenges Shorten Colds
  100. The Effect of Vitamin C on the Common Cold
  101. Zinc for the common cold
  102. Subgroup analysis of large trials can guide further research: a case study of vitamin E and pneumonia
  103. Vitamin E may affect the life expectancy of men, depending on dietary vitamin C intake and smoking
  104. Vitamin C and asthma in children: modification of the effect by age, exposure to dampness and the severity of asthma
  105. Rabies, Still Neglected after 125 Years of Vaccination
  106. Randomised trials on vitamin C
  107. The effect of β-carotene on common cold incidence is modified by age and smoking: evidence against a uniform effect in a nutrient–disease relationship
  108. The effect of vitamin C on upper respiratory infections in adolescent swimmers: a randomized trial
  109. There is no alternative medicine
  110. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
  111. Vitamin C and the treatment of tetanus
  112. Vitamin C for the common cold should not be rejected on the basis of old and erroneous articles
  113. Vitamin D Level, Respiratory Tract Infections, and Controlled Trials
  114. Vitamin E is likely to affect mortality even at low doses
  115. Predicting the incidence of human campylobacteriosis in Finland with time series analysis
  116. Modification of the Effect of Vitamin E Supplementation on the Mortality of Male Smokers by Age and Dietary Vitamin C
  117. Letter to the Editor
  118. Vitamin C supplementation for asthma
  119. Vitamins and minerals
  120. Vitamin C and exercise-induced bronchoconstriction in athletes
  121. Evidence-based medicine and the role of antioxidants in physically stressed people
  122. Vitamin E supplementation and pneumonia risk in males who initiated smoking at an early age: effect modification by body weight and dietary vitamin C
  123. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake
  124. Cochrane review: Vitamin C for preventing and treating the common cold
  125. Commentaries on ‘Vitamin C for preventing and treating the common cold’ with responses from the review author
  126. Assessment of the importance of double‐blinding should be based on systematic reviews: a rebuttal
  127. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake – reply by Hemilä & Kaprio
  128. Vitamin C for preventing and treating tetanus
  129. Vitamin C and sex differences in respiratory tract infections
  130. THE AUTHOR REPLIES
  131. Exercise, Vitamins and Respiratory Tract Infections
  132. Vitamin C may affect lung infections
  133. Vitamin C may affect lung infections
  134. Antioxidant Supplements and Mortality
  135. VITAMIN E SUPPLEMENTATION AND RESPIRATORY INFECTIONS IN OLDER PEOPLE
  136. Vitamin C for preventing and treating tetanus
  137. Vitamin C for preventing and treating the common cold
  138. Evidence-based medicine and vitamin E supplementation
  139. Vitamin C and exercise-induced immunodepression
  140. RE: "BIAS IN CLINICAL INTERVENTION RESEARCH"
  141. Conclusions about intervention effects should not be based on surrogate end points
  142. Vitamin C for preventing and treating pneumonia
  143. Small trials focusing on surrogate end points may be uninformative
  144. Letter to the Editor
  145. The Effect of Vitamin E on Common Cold Incidence Is Modified by Age, Smoking and Residential Neighborhood
  146. Physical Activity and the Risk of Pneumonia in Male Smokers Administered Vitamin E and β-Carotene
  147. Analysis of clinical data with breached blindness by Shein-Chung Chow and Jun Shao,Statistics in Medicine 2004;23:1185–1193
  148. The Protective Effect of Vitamins A and C on Endotoxin-Induced Oxidative Renal Tissue Damage in Rats
  149. Potential harm of vitamin E supplementation
  150. Vitamin C for preventing and treating pneumonia
  151. Authors' Reply
  152. Misleading Information on the Properties of Vitamin C
  153. Echinacea, Vitamin C, the Common Cold, and Blinding
  154. Assessment of blinding may be inappropriate after the trial
  155. Allocation concealment and blinding: when ignorance is bliss
  156. High-Dosage Vitamin E Supplementation and All-Cause Mortality
  157. High-Dosage Vitamin E Supplementation and All-Cause Mortality
  158. Vitamin C for Preventing and Treating the Common Cold
  159. Vitamin E and Respiratory Tract Infections in Elderly Persons
  160. Vitamin C Supplementation and Respiratory Infections: a Systematic Review
  161. Vitamin C for preventing and treating the common cold
  162. Vitamin E and Beta-Carotene Supplementation and Hospital-Treated Pneumonia Incidence in Male Smokers
  163. Vitamin C and SARS coronavirus
  164. Vitamin C, respiratory infections and the immune system
  165. Physical Activity and the Common Cold in Men Administered Vitamin E and ??-Carotene
  166. Vitamin C, Vitamin E, and Beta-Carotene in Relation to Common Cold Incidence in Male Smokers
  167. Vitamin C and Other Compounds in Vitamin C Rich Food in Relation to Risk of Tuberculosis in Male Smokers
  168. Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit
  169. Vitamin C and Infectious Diseases
  170. Nutrition Discussion Forum
  171. Vitamin C intake and susceptibility to pneumonia
  172. Blood donation, body iron stores, and risk of myocardial infarction
  173. Vitamin C intake and susceptibility to the common cold
  174. Vitamin C supplementation and common cold symptoms: Problems with inaccurate reviews
  175. To the dissent by Thomas Chalmers
  176. Vitamin C, the placebo effect, and the common cold: A case study of how preconceptions influence the analysis of results
  177. Vitamin C and Common Cold Incidence: A Review of Studies with Subjects Under Heavy Physical Stress
  178. Vitamin C and the common cold: a retrospective analysis of Chalmers' review.
  179. THE GOOD AND HARM OF VITAMIN C
  180. Does Vitamin C Alleviate the Symptoms of the Common Cold? - A Review of Current Evidence
  181. Hormone-sensitive lipase is closely related to several bacterial proteins, and distantly related to acetylcholinesterase and lipoprotein lipase: Identification of a superfamily of esterases and lipases
  182. Cloning and sequencing of a gene encoding acidophilic amylase from Bacillus acidocaldarius
  183. Vitamin C, cholesterol, and the nutritional recommendations
  184. Improving the production of E. coli β-lactamase in Bacillus subtilis: the effect of glucose, pH and temperature on the production level
  185. Sequence encoding ribosomal protein L33 of Lactococcus lactis
  186. VITAMIN C, NEUTROPHILS AND THE SYMPTOMS OF THE COMMON COLD
  187. Expression of the Erwinia carotovora polygalacturonase-encoding gene in Bacillus subtilis: role of signal peptide fusions on production of a heterologous protein
  188. Vitamin C and the common cold
  189. Vitamin C and plasma cholesterol
  190. Lipoamide dehydrogenase of Staphylococcus aureus: nucleotide sequence and sequence analysis
  191. Vitamin C and lowering of blood pressure: need for intervention trials?
  192. Nucleotide sequence of a Lactococcus lactis gene cluster encoding adenylate kinase, initiation factor 1 and ribosomal proteins
  193. Production of heterologous proteins in Bacillus subtilis: the effect of the joint between signal sequence and mature protein on yield
  194. Nucleotide sequence of the secY gene from Lactococcus lactis and identification of conserved regions by comparison of four SecY proteins
  195. Sequence of a PAL-related lipoprotein fromBacillus subtilis
  196. Sequence of a PAL-related lipoprotein from Bacillus subtilis
  197. Production of pectin methylesterase from Erwinia chrysanthemi B374 in Bacillus subtilis
  198. Is there a biochemical basis for ‘nutrient need’?
  199. The secretory S complex in Bacillus subtilis is identified as pyruvate dehydrogenase
  200. Secretory S complex of Bacillus subtilis: sequence analysis and identity to pyruvate dehydrogenase.
  201. Production of diphtheria toxin CRM228 in B. subtilis
  202. Production of diphtheria toxin CRM228 inB. subtilis
  203. A re-evaluation of nutritional goals -not just deficiency counts
  204. Retinoids Activate Superoxide Production by Polymorphonuclear Leucocytes
  205. Activated polymorphonuclear leucocytes consume vitamin C
  206. Nutritional need versus optimal intake